Cargando…
COVID‐19 and hypertension—evidence and practical management: Guidance from the HOPE Asia Network
There are several risk factors for worse outcomes in patients with coronavirus 2019 disease (COVID‐19). Patients with hypertension appear to have a poor prognosis, but there is no direct evidence that hypertension increases the risk of new infection or adverse outcomes independent of age and other r...
Autores principales: | Kario, Kazuomi, Morisawa, Yuji, Sukonthasarn, Apichard, Turana, Yuda, Chia, Yook‐Chin, Park, Sungha, Wang, Tzung‐Dau, Chen, Chen‐Huan, Tay, Jam Chin, Li, Yan, Wang, Ji‐Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361740/ https://www.ncbi.nlm.nih.gov/pubmed/32643874 http://dx.doi.org/10.1111/jch.13917 |
Ejemplares similares
-
Insights on home blood pressure monitoring in Asia: Expert perspectives from 10 countries/regions
por: Wang, Ji‐Guang, et al.
Publicado: (2020) -
Non‐pharmacological management of hypertension
por: Verma, Narsingh, et al.
Publicado: (2021) -
Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network
por: Kario, Kazuomi, et al.
Publicado: (2020) -
Hypertension and stroke in Asia: A comprehensive review from HOPE Asia
por: Turana, Yuda, et al.
Publicado: (2020) -
Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe
por: Lin, Donna S.‐H., et al.
Publicado: (2020)